PRDM15 Activators are a select group of chemical compounds that specifically enhance the activity of the PRDM15 protein through their interactions with various cellular mechanisms. PRDM15, a PR-domain containing protein, is intricately involved in the regulation of gene expression, cellular differentiation, and the maintenance of stem cell pluripotency. The activators of PRDM15 are designed to amplify its functional role by stabilizing the protein, facilitating its interaction with chromatin, or enhancing its transcriptional regulation capabilities. These compounds may work by binding directly to PRDM15, altering its conformation in a way that promotes its activity. Alternatively, they could interact with the molecular pathways that regulate the post-translational modifications of PRDM15, such as phosphorylation or ubiquitination processes, which are critical for its full activity. By ensuring the protein is correctly modified and active, these activators contribute to the precise gene expression patterns that are essential for normal cellular functions.
The precise mechanisms by which PRDM15 Activators exert their influence are varied and depend on the particular chemical structure and properties of each compound. Some may mimic cofactors or molecules that interact with PRDM15, enhancing its ability to bind DNA and regulate target genes. Others might interfere with negative regulatory mechanisms that ordinarily serve to keep PRDM15 activity in check, thereby indirectly increasing the protein's function. These activators may also the degradation of PRDM15, ensuring a sustained presence in the nucleus where it can effectively engage in the regulation of gene transcription. This sustained activation of PRDM15 can lead to the upregulation of genes that are critical for cell identity and fate determination. Collectively, PRDM15 Activators work to ensure that the biological processes governed by PRDM15 are executed with enhanced efficiency and fidelity, supporting the genomic stability and transcriptional networks essential for cellular homeostasis and development.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP activates PKA (protein kinase A), which can then phosphorylate various substrates, potentially enhancing the transcriptional regulatory functions of PRDM15. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which can influence numerous signaling pathways. Activation of PKC may enhance PRDM15's role in chromatin modification and gene expression by altering the phosphorylation status of proteins interacting with PRDM15. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent protein kinases. These kinases may indirectly enhance PRDM15's activity by modulating proteins that interact with PRDM15 in gene regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that causes hyperacetylation of histones. This modification can facilitate a more open chromatin state, potentially enhancing the transcriptional activity of PRDM15 by making its target genes more accessible. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts through its nuclear receptors which can lead to changes in gene expression. It can influence the activity of PRDM15 by affecting the transcription of genes that are co-regulated or interact with PRDM15. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to be a kinase inhibitor that could modify signaling pathways by inhibiting kinases that phosphorylate PRDM15 or its cofactors, thereby potentially augmenting PRDM15's transcriptional activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol can activate sirtuin 1 (SIRT1), a deacetylase, which might influence PRDM15 activity by deacetylating PRDM15 or associated proteins, thus affecting PRDM15’s ability to regulate gene expression. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate acts via G protein-coupled receptors to activate downstream kinases that could phosphorylate and activate cofactors of PRDM15, potentially enhancing its activity in gene regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that alters AKT signaling. By modulating this pathway, LY294002 may influence the activity of PRDM15 indirectly by affecting the phosphorylation status of PRDM15 or its associated proteins. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which can affect the translation of specific proteins. Reduced translation of negative regulators of PRDM15 could result in an indirect enhancement of PRDM15’s functional activity. | ||||||